Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupert Austin

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
SAR studies on thiazolo[4,5-d]pyrimidine based CXCR2 antagonists involving a novel tandem displacement reactionFraser Hunt, Caroline Austin, Rupert Austin, et al.
Clinical and Translational Science|March 29, 2019
Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid CancerJoachim Grevel, Garrit Jentsch, Rupert Austin, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
Evaluation of a series of bicyclic CXCR2 antagonistsIain Walters, Caroline Austin, Rupert Austin, et al.
Journal of Medicinal Chemistry|March 6, 2014
Cathepsin C inhibitors: property optimization and identification of a clinical candidateMark Furber, Anna-Karin Tiden, Philip Gardiner, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Bioorganic & Medicinal Chemistry Letters|March 27, 2007
SAR studies on thiazolo[4,5-d]pyrimidine based CXCR2 antagonists involving a novel tandem displacement reactionFraser Hunt, Caroline Austin, Rupert Austin, et al.
Clinical and Translational Science|March 29, 2019
Exposure-Response Modeling and Simulation of Progression-Free Survival and Adverse Events of Sorafenib Treatment in Patients With Advanced Thyroid CancerJoachim Grevel, Garrit Jentsch, Rupert Austin, et al.
Bioorganic & Medicinal Chemistry Letters|February 2, 2008
Evaluation of a series of bicyclic CXCR2 antagonistsIain Walters, Caroline Austin, Rupert Austin, et al.
Journal of Medicinal Chemistry|March 6, 2014
Cathepsin C inhibitors: property optimization and identification of a clinical candidateMark Furber, Anna-Karin Tiden, Philip Gardiner, et al.
Pageof 3